{"nctId":"NCT01849497","briefTitle":"Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen","startDateStruct":{"date":"2013-04-18","type":"ACTUAL"},"conditions":["Primary Hypercholesterolemia","Mixed Dyslipidemia"],"count":149,"armGroups":[{"label":"Evolocumab PFS","type":"EXPERIMENTAL","interventionNames":["Biological: Evolocumab Pre-filled Syringe"]},{"label":"Evolocumab AI/pen","type":"EXPERIMENTAL","interventionNames":["Biological: Evolocumab AI/pen"]}],"interventions":[{"name":"Evolocumab Pre-filled Syringe","otherNames":["AMG 145","Repatha"]},{"name":"Evolocumab AI/pen","otherNames":["AMG 145","Repatha"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Fasting LDL-C at screening \\> 85 mg/dL\n* Fasting triglycerides less than or equal to 400 mg/dL (4.5 mmol/L) Exclusion Criteria:\n* New York Heart Association (NYHA) III or IV heart failure\n* Uncontrolled cardiac arrhythmia\n* Uncontrolled hypertension\n* Type 1 diabetes or poorly controlled type 2 diabetes\n* Uncontrolled hypothyroidism or hyperthyroidism","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Participants With Full Administration of Evolocumab at Both Weeks 2 and 4","description":"Self-administration of evolocumab was assessed by a telephone interview at Weeks 2 and 4. Each participant was asked about all attempted injection(s) and if the injection was administered in part, full, or none at all.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"96.0","spread":null},{"groupId":"OG001","value":"89.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in LDL-C at Week 6","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-59.74","spread":"2.57"},{"groupId":"OG001","value":"-63.43","spread":"2.67"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":75},"commonTop":["Headache"]}}}